ABIDETX.COM SERVER
We detected that the main root page on abidetx.com took five thousand three hundred and ninety-two milliseconds to load. I could not discover a SSL certificate, so therefore our crawlers consider this site not secure.
SERVER SOFTWARE
We detected that this website is weilding the Apache operating system.SITE TITLE
Abide Therapeutics An Innovative Therapeutics Platform Targeting Serine HydrolasesDESCRIPTION
Research Technology. News Events. To develop innovative medicines that target serine hydrolases, one of the largest enzyme classes in nature with validated but mostly untapped therapeutic potential. To be the world leader in realizing the therapeutic value of novel serine hydrolase inhibitors. Abide Therapeutics Announces a Collaborative Agreement with the University of Oxford Read More. Abide Therapeutics Appoints Nancy Thornberry to Board of Directors Read More.PARSED CONTENT
The site abidetx.com states the following, "To develop innovative medicines that target serine hydrolases, one of the largest enzyme classes in nature with validated but mostly untapped therapeutic potential." I noticed that the website stated " To be the world leader in realizing the therapeutic value of novel serine hydrolase inhibitors." They also stated " Abide Therapeutics Announces a Collaborative Agreement with the University of Oxford Read More. Abide Therapeutics Appoints Nancy Thornberry to Board of Directors Read More."